167 related articles for article (PubMed ID: 33199724)
1. Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives.
Annas D; Cheon SY; Yusuf M; Bae SJ; Ha KT; Park KH
Sci Rep; 2020 Nov; 10(1):19889. PubMed ID: 33199724
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
[TBL] [Abstract][Full Text] [Related]
3. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
[TBL] [Abstract][Full Text] [Related]
4. A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death.
Kim EY; Chung TW; Han CW; Park SY; Park KH; Jang SB; Ha KT
Sci Rep; 2019 Mar; 9(1):3969. PubMed ID: 30850682
[TBL] [Abstract][Full Text] [Related]
5. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional regulation of lactate dehydrogenase-A in cancer.
Woodford MR; Chen VZ; Backe SJ; Bratslavsky G; Mollapour M
Future Med Chem; 2020 Mar; 12(5):439-455. PubMed ID: 32064930
[TBL] [Abstract][Full Text] [Related]
7. Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.
Rani R; Kumar V
J Med Chem; 2016 Jan; 59(2):487-96. PubMed ID: 26340601
[TBL] [Abstract][Full Text] [Related]
8. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
9. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
10. Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A.
Altamimi AS; Alafeefy AM; Balode A; Vozny I; Pustenko A; El Shikh ME; Alasmary FAS; Abdel-Gawad SA; Žalubovskis R
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):147-150. PubMed ID: 29199484
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of 1,3-benzodioxole derivatives.
Micale N; Zappalà M; Grasso S
Farmaco; 2002 Oct; 57(10):853-9. PubMed ID: 12420881
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Chen CY; Feng Y; Chen JY; Deng H
Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
[TBL] [Abstract][Full Text] [Related]
13. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
[TBL] [Abstract][Full Text] [Related]
14. Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells.
Muramatsu H; Sumitomo M; Morinaga S; Kajikawa K; Kobayashi I; Nishikawa G; Kato Y; Watanabe M; Zennami K; Kanao K; Nakamura K; Suzuki S; Yoshikawa K
Oncol Rep; 2019 Jul; 42(1):224-230. PubMed ID: 31180564
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment.
Di Magno L; Coluccia A; Bufano M; Ripa S; La Regina G; Nalli M; Di Pastena F; Canettieri G; Silvestri R; Frati L
Eur J Med Chem; 2022 Oct; 240():114605. PubMed ID: 35868126
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.
Granchi C; Fortunato S; Meini S; Rizzolio F; Caligiuri I; Tuccinardi T; Lee HY; Hergenrother PJ; Minutolo F
J Agric Food Chem; 2017 Jul; 65(28):5639-5649. PubMed ID: 28643510
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
Le A; Cooper CR; Gouw AM; Dinavahi R; Maitra A; Deck LM; Royer RE; Vander Jagt DL; Semenza GL; Dang CV
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2037-42. PubMed ID: 20133848
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment.
Balboni A; Govoni M; Rossi V; Roberti M; Cavalli A; Di Stefano G; Manerba M
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129760. PubMed ID: 33035602
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
Rai G; Brimacombe KR; Mott BT; Urban DJ; Hu X; Yang SM; Lee TD; Cheff DM; Kouznetsova J; Benavides GA; Pohida K; Kuenstner EJ; Luci DK; Lukacs CM; Davies DR; Dranow DM; Zhu H; Sulikowski G; Moore WJ; Stott GM; Flint AJ; Hall MD; Darley-Usmar VM; Neckers LM; Dang CV; Waterson AG; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2017 Nov; 60(22):9184-9204. PubMed ID: 29120638
[TBL] [Abstract][Full Text] [Related]
20. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]